Denise Miller
Gerontology · Philadelphia, PANPI 1942609532
Payments from drug & device makers
What this record shows
12 manufacturers reported payments, led by Abbott at 44.5% of the total. Reporting peaked in 2024 at $3,512 and has fallen 76.5% since, to $826 in 2025. Among gerontology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $72.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$2K
- Insightec,inc$213
- Novo Nordisk$207
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$56
- Medtronic$48
- plus $160 from 6 others
What the payments were for
- Travel & lodging$3,02858%
- Food & beverage$2,15342%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 15 | $2,303 |
| Boston Scientific | 26 | $2,194 |
| Insightec,inc | 6 | $213 |
| Novo Nordisk | 11 | $207 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $56 |
| Medtronic | 2 | $48 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| AbbVie | 1 | $28 |
| Baxter Healthcare | 1 | $28 |
| Edwards Lifesciences | 1 | $27 |
| Merck | 2 | $26 |
| GSK | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$1,963
- VERCISE$1,099
- GENERAL DBS$165
How this compares
$5,181 in reported general payments places this provider in the 95th percentile of 383 gerontology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Primidone | 65 | $734 |
| Propranolol Hcl | 30 | $322 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 13 | $217 |
| Dexamethasone | 50 | $217 |
| Gabapentin | 13 | $83 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Philadelphia
- Maria BonanniPhiladelphia$36K
- Alanna MillerPhiladelphia$9K
- Mary KelleyPhiladelphia$8K
- Yana YazmirPhiladelphia$6K
- Jacquelyn LevinPhiladelphia$4K
- Jessy PalathinkalPhiladelphia$4K
- Olivia CarrasquilloPhiladelphia$3K
- Carol GungPhiladelphia$3K
- Larena RobinsonPhiladelphia$3K
- Kimberly LeottaPhiladelphia$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.